BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register

LIMN

Liminatus Pharma, Inc. Class A Common Stock NASDAQ Listed May 1, 2025
$3.73
Pre-mkt $3.73 +0.00%
Mkt Cap $5.0M
52w Low $3.29 0.3% of range 52w High $141.50
50d MA $4.77 200d MA $15.01
P/E (TTM) -0.2x
EV/EBITDA —
P/B —
Debt/Equity -0.1x
ROE 104.0%
P/FCF -8.9x
RSI (14) 52.60
ATR (14) $0.28
Beta 0.63
50d MA $4.77
200d MA $15.01
Avg Volume 39.6K
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
CIK (SEC)
Phone
213 273 5453
6 Centerpointe Drive · La Palma, CA 90623 · US
Data updated apr 25, 2026 7:13pm · Source: financialmodelingprep.com